GenSight attended the Mitocon conference in June 5, 2015, in Bologna in Italy.

Dr Scott Urestky, MD, Neuro-ophthalmology, Clinical Development Director at GenSight, participated at a rountable within the 4th Session – Therapies – Present and future beside other pharmaceutical companies.